ʻO ka hoʻoweliweli ʻana i ka maʻi hanu i ka hoʻoilo
ʻO nā hana e hōʻemi ai i ka lawe ʻana o SARS-CoV-2 ua maikaʻi nō hoʻi i ka hōʻemi ʻana i ka lawe ʻana o nā maʻi hanu endemic ʻē aʻe.E like me ka nui o nā ʻāina e hoʻemi i ka hoʻohana ʻana i ia mau hana, e hoʻohele ʻia ʻo SARS-CoV-2 me nā maʻi hanu ʻē aʻe, e hoʻonui ana i ka nui o ka co-infections.
Wahi a ka poʻe loea e hiki mai ana ka maʻi maʻi ʻekolu i kēia hoʻoilo ma muli o ka hui pū ʻana o nā kiʻekiʻe o ka maʻi influenza (Flu) a me ka respiratory syndrome virus (RSV) me ka maʻi maʻi maʻi SARS-CoV-2.ʻOi aku ka nui o nā maʻi maʻi Flu a me RSV i kēia makahiki ma mua o ka manawa like i nā makahiki i hala.ʻO nā ʻano hou BA.4 a me BA.5 o ka maʻi SARS-CoV-2 ua hoʻonui hou i ka maʻi maʻi.
Ma ka "World Flu Day 2022 Symposium" ma Nowemapa 1, 2022, Zhong Nanshan, he mea hoʻonaʻauao o ka Chinese Academy of Engineering, ua nānā pono i ke kūlana o ka maʻi maʻi ma ka home a ma waho, a hana i ka noiʻi hou loa a me ka hoʻoholo i ke kūlana o kēia manawa."Ke kū nei ka honua i ka pilikia o nā maʻi maʻi superimposed o ka maʻi maʻi maʻi SARS-CoV-2 a me ka maʻi maʻi influenza."Ua kuhikuhi ʻo ia, "ʻOi aku i kēia hoʻoilo, pono e hoʻoikaika i ka noiʻi ʻana i nā pilikia ʻepekema o ka pale ʻana a me ka mālama ʻana i ka influenza."Wahi a nā helu helu o ka US CDC, ua hoʻonui nui ʻia ka helu o nā kipa haukapila no nā maʻi hanu ma ʻAmelika Hui Pū ʻIa ma muli o ka hui pū ʻana o ka maʻi influenza a me nā maʻi coronary hou.
ʻO ka piʻi ʻana o nā mākaʻikaʻi RSV a me nā kipa ʻoihana pilikia pili i ka RSV a me nā hale hoʻokipa ma nā wahi he nui o US, me kekahi mau wahi e kokoke ana i nā pae kiʻekiʻe o ka wā.I kēia manawa, ua piʻi ka nui o nā maʻi maʻi RSV ma US i ka kiʻekiʻe kiʻekiʻe loa i 25 mau makahiki, e hoʻopilikia ana i nā halemai o nā keiki, a ua pani ʻia kekahi mau kula.
Ua puka mai ka maʻi maʻi maʻi maʻi maʻi ma Australia i ʻApelila o kēia makahiki a kokoke i 4 mau mahina.Ma ka lā 25 o Kepakemapa, ua loaʻa he 224,565 mau maʻi i hoʻopaʻa ʻia i ka maʻi maʻi maʻi i hoʻopaʻa ʻia e ka hale hana, a he 305 mau make pili.Ma ka hoʻohālikelike ʻana, ma lalo o ka SARS-CoV-2 ka mea e pale ai i ka maʻi maʻi maʻi maʻi, aia ma kahi o 21,000 mau maʻi maʻi ma Australia i 2020 a ma lalo o 1,000 i 2021.
ʻO ka hōʻike 35 o ka pule hebedoma o China Influenza Center ma 2022 e hōʻike ana i ka nui o nā hihia influenza ma nā panalāʻau ʻākau ua ʻoi aku ka kiʻekiʻe ma mua o ke kiʻekiʻe o ka manawa like ma 2019-2021 no 4 mau pule, a ʻoi aku ka koʻikoʻi o ke kūlana e hiki mai ana.Ma ka waena o Iune, ua hoʻonui ʻia ka nui o nā maʻi influenza-like ma Guangzhou i ka 10.38 mau manawa i hoʻohālikelike ʻia me ka makahiki i hala.
ʻO nā hopena o kahi noiʻi hoʻohālike 11 mau ʻāina i hoʻokuʻu ʻia e The Lancet Global Health i ʻOkakopa i hōʻike ʻia ua piʻi ka maʻalahi o ka heluna kanaka i kēia manawa i ka maʻi influenza a hiki i 60% i hoʻohālikelike ʻia ma mua o ke ahulau.Ua wānana pū ʻia e piʻi aʻe ka piʻi nui o ka manawa maʻi 2022 e 1-5 mau manawa, a e piʻi ka nui o ke ahulau a hiki i 1-4 mau manawa.
212,466 mau mākua me ka maʻi SARS-CoV-2 i hoʻokomo ʻia i ka haukapila.Ua hoʻopaʻa ʻia nā hoʻokolohua no nā maʻi maʻi viral respiratory no 6,965 mau mea maʻi me SARS-CoV-2.Ua ʻike ʻia ka maʻi maʻi maʻi i loko o 583 (8·4%) maʻi: 227 nā mea maʻi i loaʻa i nā maʻi maʻi influenza, 220 nā mea maʻi i loaʻa i ka respiratory syncytial virus, a he 136 nā maʻi i loaʻa i nā adenovirus.
ʻO ka hui pū ʻana me nā maʻi influenza i pili me ka piʻi nui o ka loaʻa ʻana o ka invasive mechanical ventilation i hoʻohālikelike ʻia me SARS-CoV-2 mono-infection.ʻO nā maʻi maʻi SARS-CoV-2 me nā maʻi maʻi influenza a me nā adenovirus i pili nui ʻia me ka piʻi nui o ka make.ʻO ka OR no ka invasive mechanical ventilation i ka maʻi influenza co-infection he 4.14 (95% CI 2.00-8.49, p=0.0001).ʻO ka OR no ka make i loko o ka haukapila i nā maʻi i hoʻopili ʻia i ka maʻi influenza he 2.35 (95% CI 1.07-5.12, p=0.031).ʻO ka OR no ka make i loko o ka haukapila i nā maʻi i hoʻopili ʻia i ka adenovirus he 1.6 (95% CI 1.03-2.44, p=0.033).
Hōʻike maopopo ʻia nā hopena o kēia haʻawina ʻo ka co-infection me ka maʻi SARS-CoV-2 a me ka maʻi maʻi influenza he kūlana weliweli loa.
Ma mua o ka puka ʻana mai o ka SARS-CoV-2, ua like loa nā hōʻailona o nā maʻi hanu like ʻole, akā ʻokoʻa nā ʻano hana.Inā ʻaʻole hilinaʻi ka poʻe maʻi i nā hoʻokolohua he nui, e paʻakikī hou ka mālama ʻana i nā maʻi hanu, a e hoʻopau maʻalahi ia i nā kumuwaiwai o ka haukapila i nā kau kiʻekiʻe.No laila, he nui nā ho'āʻo hui like ʻana i ka maʻi maʻi maʻi, a hiki i nā kauka ke hāʻawi i ka maʻi ʻokoʻa o nā pathogens i nā maʻi me nā hōʻailona hanu ma o kahi laʻana swab hoʻokahi.
Macro & Micro-Test SARS-CoV-2 Respiratory Multiple Joint Detection Solution
Loaʻa i ka Macro & Micro-Test nā kahua ʻenehana e like me ka fluorescent quantitative PCR, isothermal amplification, immunization, a me ka molecular POCT, a hāʻawi i nā ʻano mea like ʻole o ka SARS-CoV-2 respiratory joint detection products.Ua loaʻa i nā huahana āpau ka palapala hōʻoia EU CE, me ka hana maikaʻi o ka huahana a me ka ʻike mea hoʻohana maikaʻi.
1. ʻO ka pahu RT-PCR ʻōniʻoniʻo maoli no ka ʻike ʻana i ʻeono ʻano o nā maʻi maʻi hanu
Hoomalu Kuloko: E nānā pono i ke kaʻina hana hoʻokolohua e hōʻoia i ka maikaʻi o nā hoʻokolohua.
Kiekie Efficiency: ʻIke ʻo Multiplex real-time PCR i nā pahuhopu like ʻole no SARS-CoV-2, Flu A, Flu B, Adenovirus, Mycoplasma pneumoniae, a me Respiratory syncytial virus.
ʻIke kiʻekiʻe: 300 Kope/mL no SARS-CoV-2, 500 Kope/mL no ka ma'i influenza A, 500 Kope/mL no ka ma'i influenza B, 500 Kope/mL no ka ma'i hanu syncytial, 500 Kope/mL no ka mycoplasma pneumoniae, a me 500Copieso.
2. ʻO SARS-CoV-2/Influenza A/Influenza B Nucleic Acid Combined Detection Kit (Fluorescence PCR)
Hoomalu Kuloko: E nānā pono i ke kaʻina hana hoʻokolohua e hōʻoia i ka maikaʻi o nā hoʻokolohua.
Kiekie Efficiency: ʻIke ʻo Multiplex real-time PCR i nā pahuhopu like ʻole no SARS-CoV-2, Flu A a me Flu B.
ʻIke kiʻekiʻe: 300 Kope/mL o SARS-CoV-2,500 Kope/mL o lFV A a me 500 Kope/mL o lFV B.
3. ʻO SARS-CoV-2, Influenza A a me Influenza B Antigen Detection Kit (Immunochromatography)
E hoʻohana maʻalahi
ʻO ka lawe ʻana a me ka mālama ʻana i ka lumi ma 4-30 ° ℃
Kiʻekiʻe sensitivity & specificity
| inoa mea kūʻai | Hōʻike |
| ʻO ka pahu RT-PCR fluorescent manawa maoli no ka ʻike ʻana i ʻeono ʻano o nā maʻi maʻi hanu | 20 ho'āʻo/kit,48 hōʻike / pahu,50 ho'āʻo / pahu |
| SARS-CoV-2/Influenza A/Influenza B Nucleic Acid Combined Detection Kit (Fluorescence PCR) | 48 hōʻike / pahu,50 ho'āʻo / pahu |
| SARS-CoV-2, Influenza A a me Influenza B Antigen Detection Kit (Immunochromatography) | 1 ho'āʻo/kit,20 ho'āʻo/kit |
Ka manawa hoʻouna: Dec-09-2022